The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance

Table 2

New NNRTIs that are approved or are undergoing clinical development.

Drug candidate	Chemical structure	Phase of development
ETR		Approved (2008)
RPV		Approved (2011)
TMC 120		License for HIV-1 microbicide development
RDEA806		IIb
Lersivirine; (UK-453061)		IIb